NRSN insider buying and SEC filings, explained
NeuroSense Therapeutics Ltd. · CIK 1875091
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 16, 2026 | Other purchase | Alon Ben-Noon (CEO) bought 250,000 Ordinary Shares at $0.8000 ($200K) in a private placement. Holdings up 6% to 4,534,233 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 17, 2026 |
| Jun 16, 2026 | Other purchase | Or Eisenberg (CFO) bought 250,000 Ordinary Shares at $0.8000 ($200K) in a private placement. Holdings up 20% to 1,504,050 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 17, 2026 |
3 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow NRSN in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.